ProCE Banner Activity

CE / CME

Current Topics in Obstructive Sleep Apnea: Treatment of Excessive Daytime Sleepiness

Interactive Video Lecture

Excessive daytime sleepiness (EDS) is an underdiagnosed and undertreated condition that negatively impacts health and quality of life in people with obstructive sleep apnea (OSA). Residual EDS can continue to affect patients after sleep apnea therapy is optimized. In this program, expert faculty discuss guideline-supported recommendations for diagnosis and assessment of EDS in OSA and appropriate uses of novel and emerging agents for pharmacologic treatment. An interwoven case illustrates patient-centered strategies for management of EDS in the setting of OSA.

Registered Nurses: 1.00 Nursing contact hours, includes 1.00 hour of pharmacology credit Physician Assistants: maximum of 1.00 hours of AAPA Category 1 CME credits

Released: January 28, 2022

Expiration: January 27, 2023

No longer available for credit.
Begin Activity

Share

Faculty

Ann Cartwright

Ann Cartwright, PA-C

Physician Assistant/Instructor
Division of Pulmonary, Critical Care, and Sleep Medicine
University of Colorado School of Medicine
UCHealth Sleep Medicine Clinic
Aurora, Colorado

Karl Doghramji

Karl Doghramji, MD

Professor of Psychiatry, Neurology, and Medicine
Medical Director, Jefferson Sleep Disorders Center
Program Director, Fellowship in Sleep Medicine
Thomas Jefferson University
Philadelphia, Pennsylvania

Corinne R. Young

Corinne R. Young, MSN, FNP-C

Founder and President
Association of Pulmonary Advanced Practice Providers
Pulmonary Nurse Practitioner
Colorado Springs, Colorado

Acknowledgement

This program is cosupported by educational grants from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson; Genentech, a member of the Roche Group; GlaxoSmithKline; Jazz Pharmaceuticals, Inc.; and Mylan Specialty L.P.

This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.

Provided by

ProCE Banner

Target Audience

NPs and PAs in pulmonary medicine

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Apply guideline-supported recommendations for diagnosis and assessment of EDS in OSA

  • Develop personalized management strategies for EDS in OSA

  • Determine appropriate uses of novel and emerging agents for the pharmacologic treatment of EDS in OSA

Disclosure

Ms Cartwright has no relevant financial relationships to disclose.

Dr Doghramji: consulting fees: Eisai, Idorsia, Imbrium, Pfizer; contracted research/consulting fees: Harmony, Inspire, Jazz; ownership interest: Merck.

Ms Young has no relevant financial relationships to disclose.

None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose

CME Info

Participants wishing to earn CE/CME credit must:

  1. View the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete the evaluation form

The estimated time to complete this activity is 1.00 hour.

Release date: January 28, 2022
Expiration date: January 27, 2023

Format

Interactive video lecture

Disclaimer

The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.

Accreditation

PCE

Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

NP course advisor: Corinne R. Young, MSN, FNP-C, FCCP, Association of Pulmonary Advanced Practice Providers, Colorado Springs, Colorado

Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit

AAPA Credit Designation

Joint AccreditationPracticing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until January 27, 2023. PAs should only claim credit commensurate with the extent of their participation.

PA course advisor: John Hardisty, MS, MSPAS, PA-C, Colorado Springs Pulmonary Consultants, Colorado Springs, Colorado

IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.

Additional Information

Program Medium

This program has been made available online.